^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SHR-4602

    i
    Other names: SHR-4602, SHR4602, SHR 4602
    Associations
    News

    Trials

    Company:
    Jiangsu Hengrui Pharma
    Drug class:
    Microtubule inhibitor, HER2-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors (SHR-4602-I-101) (NCT05819684)
    Phase 1
    Suzhou Suncadia Biopharmaceuticals Co., Ltd.
    Recruiting
    Last update posted :
    05/17/2023
    Initiation :
    05/06/2023
    Primary completion :
    05/30/2025
    Completion :
    05/30/2026
    HER-2
    |
    HER-2 mutation • HER-2 expression
    |
    SHR-4602